Majed Alghamdi

Dr. Majed Alghamdi Consultant Radiation Oncologist

Years of Experience : 10

Nationality : Saudi Arabia

Languages Known : Arabic, English



Dr. Majed Alghamdi is an accomplished consultant Radiation Oncologist, holding both the American and Canadian boards in radiation oncology and subspecializing in Central Nervous System Cancers, Stereotactic Radiosurgery, and Stereotactic Body Radiotherapy (CNS, SRS, SBRT). With extensive expertise in the field, Dr. Alghamdi has proven himself as a leader in the medical community through his diverse roles and contributions. Dr. Alghamdi’s commitment to advancing medical knowledge is evident through his active involvement in numerous academic and other activities. He currently holds the position of the chairman of the board at the Saudi Association of Radiation Oncology (SARO), which is a scientific non-profit society aiming to advance the safe and effective practice of radiation oncology in Saudi Arabia. As an experienced medical educator, Dr. Alghamdi serves as a member of the Examination Committee at the Saudi Commission for Health Specialties, contributing to the growth and development of Radiation Oncology Saudi residency programs. Dr. Alghamdi’s academic pursuits have also extended to the business realm, where he has pursued an MBA at Prince Mohammed Bin Salman College, exemplifying his multifaceted approach to professional development. Throughout his career, Dr. Alghamdi has been using different and advanced radiotherapy techniques to treat complex cases of cancer. His technical expertise is remarkable, encompassing a wide range of state-of-the-art treatments and technologies such as Stereotactic Body Radiotherapy (SBRT)/Stereotactic Ablative Body Radiotherapy (SABR), Linac-based Stereotactic Radiosurgery (Elekta and Novalis units), Gamma Knife Stereotactic Radiosurgery, CyberKnife Stereotactic Radiosurgery, Spine SBRT, Lung SBRT, IMRT/VMAT/3D-CRT, Liver SBRT, and Pancreas SBRT. He has used different treatment planning platforms, including using Eclipse (Varian), Pinnacle, and Monaco (Elekta). With Canadian and American board certifications and active memberships in organizations such as the Royal College of Physicians and Surgeons of Canada (FRCPC), the American Board of Radiology (ABR), and the Saudi Commission for Health Specialties (SCHS), Dr. Majed Alghamdi consistently demonstrates his commitment to excellence, research, and patient care in the field of Radiation Oncology.

Awards & Achievements

  • Award of Distinguished Trainee, Saudi Arabian Cultural Bureau 2017
  • Award of Distinguished Trainee, Saudi Arabian Cultural Bureau 2016
  • Award of Distinguished Trainee, Saudi Arabian Cultural Bureau 2015
  • Distinguished Graduate (Top 10) From College of Medicine at King Abdul Aziz University 2008 Awarded By Prince Khaled Al Faisal

Research & Publications

  • Spinal Cord Tolerance and Risk of Radiation Myelopathy, Second edition in “Adult CNS Radiation Oncology: Principles and Practice“ textbook by Springerâ submitted 2023
  • Spinal Cord Tolerance and Risk of Radiation Myelopathy, First edition in “Adult CNS Radiation Oncology: Principles and Practice“ textbook by Springerâ 2018 (
  • Treatment Planning for Skull Base and Spinal Chordoma and Chondrosarcoma in “Intracranial and Spinal Radiotherapy: A Practical Guide on Treatment Techniques“ textbook by Springerâ 2020 (
  • Cancer in Saudi Arabia in “Cancer in the Arab World” textbook by Springerâ 2021 (
  • A Retrospective Evaluation of the Value of COVID-19 Screening and Testing in Patients with Cancer: Aiming at a Moving Target Abdul Rahman Jazieh, Majed Alghamdi, Mohammad Alkaiyat, Sameera M. Al Johani,, Moussab Damlaj. Journal of infection and public health, accepted for publication, April 2021
  • Scholarly Activity of Radiation Oncologists in High-Income Developing Countries: Saudi Arabia As An Example Majed Alghamdi, Suliman Alghamdi, Yasir Bahadur, Mushabbab Asiri,Hussain AlHussain, Adnan Alhebshi, Majed Alothman, Ameen Al-omair, Abdulaziz Alghamdi, Ahmed Qanat, Mohammed Aqeeli, Abdullah Alsuhaibani, Salem Alshehri, Ibrahim Alotain, Noor Mail, Hashem Alhashemi, and Hossam Alassaf. JCO Global Oncology, Accepted for 2021 publication
  • Contribution of Pathologists in Leading Clinical Cancer Research Through Interdisciplinary Collaboration in Saudi Arabia Moataz Muwar, Alaa Samkari and Majed Alghamdi, Cureus 2020 Sep 17;12(9):e10513. doi: 10.7759.10513
  • Locally Advanced Oral Cavity Cancers: What Is the Optimal Care? Alzahrani R, Obaid A, Al-Hakami H, Alshehri A, Al-Assaf H, Adas R, Alduhaibi E, Alsafadi N, Alghamdi S, Alghamdi M. Cancer Control. 2020 Jan-Dec;27(1):1073274820920727. doi: 10.1177/1073274820920727
  • Oncology Research in Saudi Arabia over a 10-year Period. A Synopsis Alghamdi MA, Alzahrani RA, Alhashemi HH, Obaid AA, Alghamdi AG, Aldokhi MA, Alghamdi AM, Alghamdi AA, Qanat AS, Jastaniah WA, Alghamdi SM. Saudi Med J. 2020 Mar;41(3):261-266. doi: 10.15537/smj.2020.3.24912
  • Highlights on the Management of Oligometastatic Disease Salem M Alshehri, Khaled Alkattan, Ahmed Abdelwarith, Hussain Alhussain, Shaker Shaker, Majed Alghamdi, Hossam Alassaf, Ali Albargawi, Manal Al Naimi, Ameen Alomair, Saif Althaqfi, Adnan Alhebshi, Majed Alothman, AbdulRahman Jazieh. J Immunother Precis Oncol (ahead of print, cited 2020 Feb 9)
  • Post-operative Stereotactic Body Radiotherapy for Spinal Metastases and the Impact of Epidural Disease Grade Majed Alghamdi, Arjun Sahgal, Hany Soliman, Sten Myrehaug, MD, Victor X.D. Yang, Sunit Das, Jefferson Wilson, Mikki Campbell, Young K Lee, Monica Cawricz, Leo Da Costa, Eshetu G. Atenafu, Chia-Lin Tseng. Neurosurgery. 2019 Sep 10. pii: nyz349. doi: 10.1093/neuros/nyz349
  • Stereotactic radiosurgery for resected brain metastasis: Cavity dynamics and factors affecting its evolution Alghamdi M, Hasan Y, Ruschin M, Atenafu EG, Myrehaug S, Tseng CL, Spears J, Mainprize T, Sahgal A, Soliman H. J Radiosurg SBRT. 2018;5(3):191-200
  • Clinical implementation of AXB from AAA for breast: Plan quality and subvolume analysis Guebert A, Conroy L, Weppler S, Alghamdi M, Conway J, Harper L, Phan T, Olivotto IA, Smith WL, Quirk S. J Appl Clin Med Phys. 2018 May;19(3):243-250. doi: 10.1002/acm2.12329. Epub 2018 Apr 25
  • Vertebral Compression Fracture After Spine Stereotactic Body Radiation Therapy: A Review of the Pathophysiology and Risk Factors Faruqi S, Tseng CL, Whyne C, Alghamdi M, Wilson J, Myrehaug S, Soliman H, Lee Y, Maralani P, Yang V, Fisher C, Sahgal A. Neurosurgery. 2017 Oct 18. doi: 10.1093/neuros/nyx493. [Epub ahead of print]
  • Postoperative stereotactic body radiotherapy for spinal metastases Alghamdi M, Tseng CL, Myrehaug S, Maralani P, Heyn C, Soliman H, Lee Y, Ruschin M, Da Costa L, Yang V, Campbell M, Sahgal A.Chin Clin Oncol. 2017 Sep;6(Suppl 2):S18. doi: 10.21037/cco.2017.06.27. Review.
  • Atypical Meningioma: Referral Patterns, Treatment and Adherence to Guidelines Alghamdi M, Li H, Olivotto I, Easaw J, Kelly J, Nordal R, Lim G.Can J Neurol Sci. 2017 May;44(3):283-287. doi: 10.1017/cjn.2016.449
  • An audit of referral and treatment patterns of high-risk prostate cancer patients in Alberta Alghamdi M, Taggar A, Tilley D, Kerba M, Kostaras X, Gotto G, Sia M.Can Urol Assoc J. 2016 Nov-Dec;10(11-12):410-415. doi: 10.5489/cuaj.3910
  • Assessing guideline impact on referral patterns of post-prostatectomy patients to radiation oncologists Taggar A, Alghamdi M, Tilly D, Kostaras X, Kerba M, Husain S, Gotto G, Sia M.Can Urol Assoc J. 2016 Sep-Oct;10(9-10):314-318


  • Radiation Oncology
  • Brain metastases
  • Meningioma
  • Pituitary gland tumors
  • Vestibular schwannoma
  • Arteriovenous malformation
  • Trigeminal neuralgia
  • Glioblastoma
  • Other gliomas
  • Ependymoma
  • Medulloblastoma
  • Other brain tumors
  • Stereotactic Radiosurgery (SRS)
  • Stereotactic Body Radiotherapy ( SBRT)
  • Primary and secondary spine tumors
  • Prostate cancer
  • Bladder cancer
  • Breast cancer
  • Lung cancer
  • Gastric cancers
  • Esophageal cancers
  • Rectal cancers
  • Liver cancer
  • Lymphoma
  • Total body irradiation
  • Paediatric cancers


  • Canadian Board: Royal College of Physicians and Surgeons of Canada (FRCPC), Radiation Oncology, board certified 2016
  • American Board: Radiation Oncology (DABR), board certified 2019